Getinge Group

Shaping Health Care of tomorrow

Net Sales 10.9 billion SEK

INFECTION CONTROL

Production units 10

Sales companies 25

EXTENDED CARE

Production units 5

Sales companies 24

MEDICAL SYSTEMS

Production units 5

Sales companies 23

Shaping Health Care of tomorrow

Customer Segment70%

22%8%

Hospital 70%Longterm Care 22%Life Science 8%

Business Area

32%

25%

43%

Infection Control 32%Extended Care 25%Medical Systems 43%

Geographical regions

29% 55%

11%

5%

North America 29%W Europe 55%Asia Pacific 11%RoW 5%

Revenues 3,524 MSEK

EBITA margin 15.2 %

Customers

60%

10%

30%

HospitalElderly CareLife Science

Product Lines62%

38%

Sterilization 62%

Disinfection 38%

Geographical

45%

36%

12%7%

W Europe 45%US&Canada 36%Asia&Australia 12%RoW 7%

Infection Control- Fact sheet 2004 numbers

Revenues 2,701 MSEK

EBITA margin 18.9 %

Extended Care – Fact sheet 2004 Numbers

Customers

30% 55%

15%

Hospital 30%Elderly Care 55%Home Care 15%

Product Lines

37%

46%

17%

Patient Handling 37%Hygiene Systems 46%Wound Care 17%

Geographical65%

31%3%

1%

W Europe 65%US&Canada 31%Asia&Australia 3%RoW 1%

Revenues 4,620 MSEK

EBITA margin 15.4 %

Medical Systems – Fact sheet 2004 Numbers

Customers

100%

Hospital

Product Lines *

36%

15%

6%

27%

16%

Tables 36%Lights 15%Pendants 6%Cardio-Pulmonary 16%Critical Care 27%

Geographical

58%

20%

16%6%

W Europe 58%US&Canada 20%Asia&Australia 16%RoW 6%

Getinge Group Development

Financial deficits andunaffordable health care insurances

Shift in power balance

Technology breakthrough

Fundamental increase in

demand

Increased management of reimbursements

Increased use of competition

Increased co-payment

Cost containment

Our customers in health care respond to the changes by…

Getinge has gained a competitive position in health care that will be further strengthened by current trends

Health care policy makers will increasingly look for privatisation and market testing as tools to achieve cost efficiency

Activity based reimbursements continue to drive process efficiency

Focus on core competencies in medical processes

Elective care will be provided in outpatient facilities

Financial TargetsOur customers in the healthcare industry respond to the changes by…

Positive Outcomes

A competent solution provider in well defined niches of the health care industry

– offering solutions that enhance customers’ productivity over time

Global leadership

Strategic Cornerstones

Global leadership

We strive to be a global No 1 or No 2 in the product areas focused.Market leadership will help us attain cost leadership through scale

Infection Control Sterilization No 1Disinfection No 1

Extended Care Patient Handling No 1Hygiene Systems No 1Wound Care No 4

Medical Systems Surgical Tables No 1Surgical Lights No 1Ceiling Pendants No 3Cardiopulmonary No 3Ventilation No 1

Global leadership

Innovative solutions

Strategic Cornerstones

Innovative Solutions

We strive to combine the strength of our leading product positions and the depth of our know-how to offer innovative solutions that lead to process improvements for our customers

SterilizationDisinfectionLoad HandlingIT-systems

Hygiene SystemsPatient HandlingWound Care

Surgical TablesSurgical LightsPendants

Integratedsolutions for surgical

interventions

IntegratedInfection Control

solutions

Integrated solutions for health care

ergonomics

Competitive position

Cost Innovation

Products

System

Innovations

Leadership

Getinge

Our competitive position will be based on cost leadership and innovations in solutions

Global leadership

Innovative solutions

Direct Sales and Service approach

Strategic Cornerstones

A direct approach to our customers is crucial to our succcess Getinge will strive to establish own distribution companies whenever justifiable Solution provider

Transfer and exchange of know-how

Control all parameters that define customer satisfaction

Control the profitable after-sales market

Direct Sales & Service Approach

Growth is the backbone of our development to remain a dynamic and attractive company and to fund our targeted expansion

Growth in pretax earnings > 15% p a

Cash-flow to sustain external growth rate > 10% p a

Financial Targets

CAGR 23%

0

2000

4000

6000

8000

10000

12000

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004

0

200

400

600

800

1000

1200

1400

Invoiced sales *) Profit before tax

Results 1993 - 2004

Target A2004Organic growth 4 – 5 %

EBITA margin ~ 16 % 15.2 %

Target A2004Organic growth ~ 7 %

EBITA margin ~ 19 % 18.9 %

Target A2004Organic growth ~ 5 %

EBITA margin ~ 17 % 15.4 %

GROUP Target A2004Organic growth ~ 5 % +

EBITA margin ~ 17 % + 16.1 %

Financial Targets by Business Area

2004 Financials

Getinge AB - Financials (MSEK)

2004 2003 Change 2004 2003 Change

  Q 4 Q 4   12 Mon 12 Mon  

Orders received 2,981 2,675 11% 10,812 9,154 18%

Net sales 3,477 2,929 19% 10,889 9,160 19%

EBITA 682 544 25% 1,757 1,449 21%

EBITA % 19.6% 18.6% 16.1% 15.8%

EBIT 621 477 30% 1,505 1,257 20%

EBIT % 17.9% 16.3% 13.8% 13.7%

Profit before tax 574 432 33% 1,309 1,095 20%

Getinge AB - Key figures (MSEK)

2004 2003 2004 2003

  Q 4 Q 4 12 Mon 12 Mon

Operating Cash Flow, MSEK 584 556 1,878 1,980

Net debt, MSEK 4,705 4,852

Equity / Assets ratio, % 33.1% 29.3%

Net debt / Equity ratio, multiple 1.18 1.37

Interest cover, multiple 7.1 7.3

The Getinge group will reach its growth targets by: Development of existing positions

Organic growth

Bolt-on acquisitions

Acquisitions of new globally leading product lines that will strengthen our position as an innovative provider of solutions

Strategy for Growth

Strategy for growth 2004 – 2007 Infection Control

Principally organic growth supplemented by bolt-on acquisitions to reach new geographical territories, add new technologies in existing product lines

Strengthen solution provider capabilities

Focused approach towards the global Life Science industry

Geographical expansion

Continue to strengthen competitiveness throughimproved production structure and logistics

Strategy for growth 2004 – 2007 Extended Care

Principally organic growth on existing markets supplemented by bolt-on acquisitions to add new technologies in existing product lines

Total bed-side management in elderly care

Enter the hospital market / bariatric care

Improved supply chain for increased competitiveness

Strategy for growth 2004 – 2007 Medical Systems

Organic growth on existing markets and existing product lines Acquisitions of new globally leading product lines that will strengthen our position as an innovative solution provider with special emphasis on critical care and cardiac surgery

Position as provider of integrated solutions

Strengthen sales network in developing economies and North America

Continue to strengthen product leadership position

Develop Critical Care product portfolio through acquisitions

Getinge has gained a competitive position in its market that will be further strengthened by current trends

Infection Control is positioned to achieve solid organic growth over coming years. Efforts and activities to improve the production structure and logistics will strengthen competitiveness

Extended Care is establishing a product portfolio capable of delivering higher levels of organic growth. The hospital market for ergonomic solutions is an untapped opportunity that will be addressed

Medical Systems has created a strong base for continued external expansion in a dynamic environment. Significant scope for organic growth on emerging markets and in North America

Solid base - bright future